Earnings call transcript: Lazard Q1 2026 misses EPS, revenue beats By Investing.com

Lazard reported mixed Q1 2026 results: EPS missed at $0.42 versus $0.53 expected, while revenue beat at $757 million versus $706.34 million and rose 5% year over year. Asset Management was a bright spot, with revenue up 17% and $9 billion of net inflows, but Financial Advisory revenue fell 4% amid transaction delays. The company also announced the Campbell Lutyens acquisition to expand its private capital advisory platform and returned $174 million to shareholders, though the stock fell 5.15% premarket on the EPS miss.

Analysis

The knee-jerk selloff looks more like a margin-reset trade than a broken-franchise signal. The important second-order issue is that Lazard’s revenue mix is shifting toward businesses with higher recurring visibility and better cross-sell economics, while the miss came from timing and compensation accrual mechanics that are unusually front-loaded. That makes the stock vulnerable for a few sessions, but the setup is less toxic over a 3-6 month horizon if deal conversion and asset-management flows hold.

The acquisition is strategically more interesting than the quarter itself. Campbell Lutyens gives Lazard a new wedge into sponsor and LP/GP ecosystems where relationship density compounds over years; that should raise both wallet share and MD productivity, but the bigger implication is that it can soften cyclicality by monetizing private-market friction even when traditional M&A is sluggish. If integration is handled well, the combined platform could also improve talent recruiting by making the firm a broader platform rather than a single-product advisory shop.

The market is probably underestimating two risks: first, the comp ratio may remain structurally sticky through 2026 if they really are investing ahead of the revenue ramp; second, the asset-management inflow burst may normalize from an exceptionally strong Q1 run-rate. The contrarian bull case is that the current pullback is occurring just as Lazard is becoming less dependent on headline M&A and more levered to private capital, restructuring, and sticky flows — a mix that deserves a higher multiple if execution continues. The next catalyst window is the next 1-2 quarters, when investors can see whether transaction slippage converts and whether Campbell Lutyens adds net revenue before the integration noise hits.

Key Decisions for Investors

• Long LAZ on weakness over the next 1-2 weeks; use the post-earnings drawdown as an entry if the stock holds above the pre-market gap low. Risk/reward favors a rebound toward prior trading levels if Q2 confirms conversion of deferred deals and comp normalizes.
• Buy LAZ Jan-2027 calls or call spreads to express the 12-18 month thesis that Campbell Lutyens and private-capital advisory re-rate the multiple. This is a cleaner way to play the integration story than stock-only exposure because near-term EPS noise remains high.
• Pair trade: long LAZ / short a more M&A-cyclical advisory peer over 1-3 months. The relative case is that LAZ is adding a higher-quality private-markets annuity while pure advisory names remain exposed to deal timing and geopolitical volatility.
• If you already own LAZ, hedge the next 30-60 days with short-dated calls or a collar into the integration period. The stock can trade choppy while the market digests comp discipline and whether Q1 flows are repeatable.
• Avoid chasing the move in the next few sessions; wait for either confirmation of deal conversion in Q2 or a better technical reset. The risk/reward improves if the market sells LAZ again on generic EPS-miss headlines without evidence of slower inflows or weaker pipeline.